Literature DB >> 7853480

Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B.

H L Pahl1, P A Baeuerle.   

Abstract

Influenza virus infection initiates transcription of a variety of genes for cytokines such as tumor necrosis factor alpha (TNF-alpha), TNF-beta, interleukin 1 alpha, (IL-1 alpha), IL-1 beta, IL-2, IL-4, IL-6, IL-10, granulocyte macrophage colony-stimulating factor, and gamma interferon. However, the mechanism by which virus infection elicits cytokine expression remains unknown. Six influenza virus-induced cytokine genes are targets for the inducible transcription factor NF-kappa B, a central regulator of the human immune response. Here, we show that expression of a single influenza virus protein, the virion surface hemagglutinin, strongly activates NF-kappa B DNA binding and transactivation. Activation is inhibited in the presence of the antioxidant dithiothreitol, suggesting that, similar to the findings for previously described inducers of NF-kappa B, hemagglutinin expression generates radical oxygen intermediates which activate the transcription factor. Hemagglutinin is the first secretory and structural viral protein reported to activate NF-kappa B and thus represents a new class of inducers for this transcription factor. We discuss these results in the context of clinical complications of influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853480      PMCID: PMC188737     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulation.

Authors:  J Yodoi; T Uchiyama
Journal:  Immunol Today       Date:  1992-10

Review 2.  Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review).

Authors:  R Schreck; K Albermann; P A Baeuerle
Journal:  Free Radic Res Commun       Date:  1992

3.  Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells.

Authors:  T Takizawa; S Matsukawa; Y Higuchi; S Nakamura; Y Nakanishi; R Fukuda
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

Review 4.  The role of cachectin/TNF in endotoxic shock and cachexia.

Authors:  A Cerami; B Beutler
Journal:  Immunol Today       Date:  1988-01

Review 5.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia.

Authors:  S R Sarawar; P C Doherty
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release.

Authors:  J H Gong; H Sprenger; F Hinder; A Bender; A Schmidt; S Horch; M Nain; D Gemsa
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

8.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

9.  H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor.

Authors:  M Meyer; R Schreck; P A Baeuerle
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

10.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.

Authors:  R Schreck; B Meier; D N Männel; W Dröge; P A Baeuerle
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Role of NFkappaB in the mortality of sepsis.

Authors:  H Böhrer; F Qiu; T Zimmermann; Y Zhang; T Jllmer; D Männel; B W Böttiger; D M Stern; R Waldherr; H D Saeger; R Ziegler; A Bierhaus; E Martin; P P Nawroth
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations.

Authors:  Gijs A Versteeg; Paula S van de Nes; Peter J Bredenbeek; Willy J M Spaan
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Characterization of wild-type and mutant vaccinia virus M2L proteins' abilities to localize to the endoplasmic reticulum and to inhibit NF-kappaB activation during infection.

Authors:  Olivia Hinthong; Xiao-Lu Jin; Joanna L Shisler
Journal:  Virology       Date:  2008-01-10       Impact factor: 3.616

5.  NF-kappaB signaling differentially regulates influenza virus RNA synthesis.

Authors:  Naveen Kumar; Zhong-Tao Xin; Yuhong Liang; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

6.  Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1.

Authors:  F Demarchi; F d'Adda di Fagagna; A Falaschi; M Giacca
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

7.  Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.

Authors:  Pankaj Kumar; Sonal Sharma; MadhU Khanna; Hanumantharao Guru Raj
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

8.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 9.  Regulatory mechanisms of viral hepatitis B and C.

Authors:  G Waris; A Siddiqui
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

10.  Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells.

Authors:  P Desprès; M Flamand; P E Ceccaldi; V Deubel
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.